{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T21:19:42Z","timestamp":1791062382067,"version":"4.1.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2009,6,1]],"date-time":"2009-06-01T00:00:00Z","timestamp":1243814400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2009,6]]},"DOI":"10.1016\/j.bcp.2009.03.006","type":"journal-article","created":{"date-parts":[[2009,3,20]],"date-time":"2009-03-20T08:44:49Z","timestamp":1237538689000},"page":"1845-1853","source":"Crossref","is-referenced-by-count":26,"title":["S-adenosylmethionine regulates thiopurine methyltransferase activity and decreases 6-mercaptopurine cytotoxicity in MOLT lymphoblasts"],"prefix":"10.1016","volume":"77","author":[{"given":"Miha","family":"Milek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasa Karas","family":"Kuzelicki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alenka","family":"Smid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irena","family":"Mlinaric-Rascan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2009.03.006_bib1","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/BF02220605","article-title":"The clinical pharmacology of 6-mercaptopurine","volume":"43","author":"Lennard","year":"1992","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.bcp.2009.03.006_bib2","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0928-0987(99)00027-5","article-title":"Metabolites of mercaptopurine in red blood cells: a relationship between 6-thioguanine nucleotides and 6-methylmercaptopurine metabolite concentrations in children with lymphoblastic leukaemia","volume":"8","author":"Chrzanowska","year":"1999","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.bcp.2009.03.006_bib3","first-page":"5810","article-title":"Differing contribution of thiopurine methyltransferase to mercaptopurine versus thioguanine effects in human leukaemic cells","volume":"61","author":"Dervieux","year":"2001","journal-title":"Cancer Res"},{"key":"10.1016\/j.bcp.2009.03.006_bib4","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/sj.bjc.6602893","article-title":"Mechanistic mathematical modelling of mercaptopurine effects on cell cycle of human acute lymphoblastic leukaemia cells","volume":"94","author":"Panetta","year":"2006","journal-title":"Br J Cancer"},{"key":"10.1016\/j.bcp.2009.03.006_bib5","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/S0026-895X(24)13482-7","article-title":"6-Mercaptopurine decreases the Bcl-2\/Bax ratio and induces apoptosis in activated splenic B lymphocytes","volume":"51","author":"Hortelano","year":"1997","journal-title":"Mol Pharm"},{"key":"10.1016\/j.bcp.2009.03.006_bib6","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.bbrc.2004.04.030","article-title":"Mismatch repair-mediated G2\/M arrest by 6-thioguanine involves the ATR-Chk1 pathway","volume":"318","author":"Yamane","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.bcp.2009.03.006_bib7","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/0006-2952(69)90069-0","article-title":"Inhibition of phosphoribosyl pyrophosphate amidotransferase from Ehrlich ascites-tumor cells by thiopurine nucleotides","volume":"18","author":"Tay","year":"1969","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.bcp.2009.03.006_bib8","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1182\/blood.V93.9.2817","article-title":"Prognostic importance of 6-mercaptopurine dose intensity in acute lymphoblastic leukemia","volume":"93","author":"Relling","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2009.03.006_bib9","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0009-9236(97)90152-1","article-title":"Human thiopurine methyltransferase pharmacogenetics: gene sequence polymorphisms","volume":"62","author":"Otterness","year":"1997","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.bcp.2009.03.006_bib10","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1159\/000093278","article-title":"Thiopurine S-methyltransferase pharmacogenetics: genotype to phenotype correlation in the Slovenian population","volume":"77","author":"Milek","year":"2006","journal-title":"Pharmacology"},{"key":"10.1016\/j.bcp.2009.03.006_bib11","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1097\/01.fpc.0000174788.69991.6b","article-title":"Thiopurine S-methyltransferase pharmacogenetics: variant allele functional and comparative genomics","volume":"15","author":"Salavaggione","year":"2005","journal-title":"Pharmacogenet Genomics"},{"key":"10.1016\/j.bcp.2009.03.006_bib12","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/0140-6736(90)91745-V","article-title":"Genetic variation in response to 6-mercaptopurine for childhood acute lymphoblastic leukemia","volume":"336","author":"Lennard","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.bcp.2009.03.006_bib13","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/S0022-3476(05)83063-X","article-title":"Altered mercaptopurine metabolism, toxic effects and dosage requirement in a thiopurine methyltransferase-deficient child with acute lymphoblastic leukemia","volume":"119","author":"Evans","year":"1991","journal-title":"J Pediatr"},{"key":"10.1016\/j.bcp.2009.03.006_bib14","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1002\/prot.21272","article-title":"Structural basis of allele variation of human thiopurine-S-methyltransferase","volume":"67","author":"Wu","year":"2007","journal-title":"Proteins"},{"key":"10.1016\/j.bcp.2009.03.006_bib15","doi-asserted-by":"crossref","first-page":"6444","DOI":"10.1073\/pnas.94.12.6444","article-title":"Enhanced proteolysis of thiopurine S-methyltransferase (TPMT) encoded by mutant alleles in humans (TPMT*3A TPMT*2): mechanisms for the genetic polymorphism of TPMT activity","volume":"94","author":"Tai","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bcp.2009.03.006_bib16","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1097\/01213011-199910000-00011","article-title":"Enhanced proteasomal degradation of mutant human thiopurine S-methyltransferase (TPMT) in mammalian cells: mechanism for TPMT protein deficiency inherited by TPMT*2, TPMT*3A TPMT*3B or TPMT*3C","volume":"9","author":"Tai","year":"1999","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.bcp.2009.03.006_bib17","doi-asserted-by":"crossref","first-page":"12198","DOI":"10.1021\/bi0492556","article-title":"Consequences of binding an S-adenosylmethionine analogue on the structure and dynamics of the thiopurine methyltransferase protein backbone","volume":"43","author":"Scheuermann","year":"2004","journal-title":"Biochemistry"},{"key":"10.1016\/j.bcp.2009.03.006_bib18","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0925-4439(93)90110-M","article-title":"The importance of methylthio-IMP for methylmercaptopurine ribonucleoside (Me-MPR) cytotoxicity in Molt F4 human malignant T-lymphoblasts","volume":"1181","author":"Vogt","year":"1993","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.bcp.2009.03.006_bib19","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1042\/bj3040163","article-title":"Decrease in S-adenosylmethionine synthesis by 6-mercaptopurine and methylmercaptopurine ribonucleoside in Molt F4 human malignant lymphoblasts","volume":"304","author":"Stet","year":"1994","journal-title":"Biochem J"},{"key":"10.1016\/j.bcp.2009.03.006_bib20","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1373\/clinchem.2005.053157","article-title":"Genetic variation in the MTHFR gene influences thiopurine methyltransferase activity","volume":"51","author":"Arenas","year":"2005","journal-title":"Clin Chem"},{"key":"10.1016\/j.bcp.2009.03.006_bib21","article-title":"Heterozygosity at the TPMT gene locus, augmented by mutated MTHFR gene, predisposes to 6-MP related toxicities in childhood ALL patients","author":"Karas Kuzelicki","year":"2008","journal-title":"Leukemia"},{"key":"10.1016\/j.bcp.2009.03.006_bib22","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.taap.2008.06.019","article-title":"Surface active stabilizer Tyloxapol in colloidal dispersions exerts cytostatic effects and apoptotic dismissal of cells","volume":"232","author":"Kristl","year":"2008","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.bcp.2009.03.006_bib23","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ejpb.2007.10.004","article-title":"A novel gene delivery system for stable transfection of thiopurine-S-methyltransferase gene in versatile cell types","volume":"69","author":"Egle","year":"2008","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.bcp.2009.03.006_bib24","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1111\/j.1365-2443.2004.00794.x","article-title":"Internucleosomal DNA cleavage in apoptotic WEHI 231 cells is mediated by a chymotrypsin-like protease","volume":"9","author":"Murn","year":"2004","journal-title":"Genes Cells"},{"key":"10.1016\/j.bcp.2009.03.006_bib25","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1093\/clinchem\/44.12.2511","article-title":"Identification of 6-methylmercaptopurine derivative formed during acid hydrolysis of thiopurine nucleotides in erythrocytes, using liquid chromatography\u2013mass spectrometry, infrared spectroscopy, and nuclear magnetic resonance assay","volume":"44","author":"Dervieux","year":"1998","journal-title":"Clin Chem"},{"key":"10.1016\/j.bcp.2009.03.006_bib26","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.clinbiochem.2004.05.025","article-title":"Improved HPLC methodology for monitoring thiopurine metabolites in patients on thiopurine therapy","volume":"37","author":"Stefan","year":"2004","journal-title":"Clin Biochem"},{"key":"10.1016\/j.bcp.2009.03.006_bib27","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1016\/S0006-2952(97)00681-3","article-title":"Increased concentrations of methylated 6-mercaptopurine metabolites and 6-thioguanine nucleotides in human leukemic cells in vitro by methotrexate","volume":"55","author":"Giverhaug","year":"1998","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.bcp.2009.03.006_bib28","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0378-4347(97)00213-2","article-title":"Measuring S-adenosylmethionine in whole blood, red blood cells and cultured cells using a fast preparation method and high-performance liquid chromatography","volume":"696","author":"Wise","year":"1997","journal-title":"J Chromatogr B Biomed Sci Appl"},{"key":"10.1016\/j.bcp.2009.03.006_bib29","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1258\/000456303321016222","article-title":"Measurement of thiopurine S-methyltransferase activity in human blood samples based on high-performance liquid chromatography: reference values in erythrocytes from children","volume":"40","author":"Keizer-Garritsen","year":"2003","journal-title":"Ann Clin Biochem"},{"key":"10.1016\/j.bcp.2009.03.006_bib30","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s00228-003-0617-z","article-title":"Real-time RT-PCR methodology for quantification of thiopurine methyltransferase gene expression","volume":"59","author":"Lindqvist","year":"2003","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.bcp.2009.03.006_bib31","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1093\/nar\/29.9.e45","article-title":"A new mathematical model for relative quantification in real-time RT-PCR","volume":"29","author":"Pfaffl","year":"2001","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.bcp.2009.03.006_bib32","doi-asserted-by":"crossref","first-page":"4965","DOI":"10.1158\/0008-5472.CAN-06-3508","article-title":"Differential effects of targeted disruption of thiopurine methyltransferase on mercaptopurine and thioguanine pharmacodynamics","volume":"67","author":"Hartford","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.bcp.2009.03.006_bib33","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0006-2952(94)00387-2","article-title":"Reversal of methylmercaptopurine ribonucleoside cytotoxicity by purine ribonucleosides and adenine","volume":"49","author":"Stet","year":"1995","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.bcp.2009.03.006_bib34","first-page":"601","article-title":"Thiopurine pharmacogenetics: clinical and molecular studies of thiopurine methyltransferase","volume":"29","author":"Weinshilboum","year":"2001","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.bcp.2009.03.006_bib35","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1172\/JCI16432","article-title":"CD28-dependent Rac-1 activation is the molecular target of azathioprine in primary human CD4+ T lymphocytes","volume":"111","author":"Tiede","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.bcp.2009.03.006_bib36","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1096\/fasebj.10.4.8647346","article-title":"S-adenosylmethionine and methylation","volume":"10","author":"Chiang","year":"1996","journal-title":"FASEB J"},{"key":"10.1016\/j.bcp.2009.03.006_bib37","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/0065-2571(94)00008-Q","article-title":"Thiopurine induced disturbance of DNA methylation in human malignant cells","volume":"35","author":"De Abreu","year":"1995","journal-title":"Adv Enzyme Regul"},{"key":"10.1016\/j.bcp.2009.03.006_bib38","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.bcp.2008.07.026","article-title":"The effect of thiopurine drugs on DNA methylation in relation to TPMT expression","volume":"76","author":"Hogarth","year":"2008","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.bcp.2009.03.006_bib39","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1042\/BST0350331","article-title":"Polyamines and DNA methylation in childhood leukaemia","volume":"35","author":"Schipper","year":"2007","journal-title":"Biochem Soc Trans"},{"key":"10.1016\/j.bcp.2009.03.006_bib40","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/sj.leu.2404575","article-title":"Folate restriction and methylenetetrahydrofolate reductase 677T polymorphism decreases adoMet synthesis via folate-dependent remethylation in human-transformed lymphoblasts","volume":"21","author":"Chiang","year":"2007","journal-title":"Leukemia"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295209001816?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295209001816?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T15:53:55Z","timestamp":1739030035000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295209001816"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6]]},"references-count":40,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2009,6]]}},"alternative-id":["S0006295209001816"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2009.03.006","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2009,6]]}}}